Man labioscrotal folds into the scrotum. Another significant hormone in sexual differentiation is the anti-Müllerian hormone, which inhibits development of the Müllerian ducts. In general, men suffer from many of the same illnesses as women. In comparison to women, men suffer from slightly more illnesses. Male life expectancy is slightly lower than female life expectancy, although the difference has narrowed in recent years. For males during puberty, testosterone, along with gonadotropins released by the pituitary gland, stimulates spermatogenesis, along with the full sexual distinction of a human male from a human female, while women are acted upon by estrogens and progesterone
Transgender hormone therapy (female-to-male) Transgender hormone therapy (female-to-male) Transgender hormone therapy of the female-to-male (FTM) type, also known as masculinizing hormone therapy, is a form of hormone therapy and sex reassignment therapy which is used to change the secondary sexual characteristics of transgender people from feminine (or androgynous) to masculine. It is one of two types of transgender hormone therapy (the other being male-to-female), and is predominantly used to treat transgender men and other transmasculine individuals. Some intersex people also receive this form of therapy, either starting in childhood to confirm the assigned sex or later if the assignment proves to be incorrect. The